Minimal Residual Disease (Mrd) Based Preemptive 5-Azacytidine Treatment Can Prevent Or Delay Imminent Relapse In Patients With High-Risk Mds Or Aml After Allogenic Hsct - Results Of The "Relaza" Trial
BLOOD（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要